MEDIPOST Co., Ltd. (KOSDAQ:078160)
South Korea · Delayed Price · Currency is KRW 20,250
+450 (2.27%)
Apr 10, 2026, 3:30 PM KST
MEDIPOST Revenue
In the year 2025, MEDIPOST had annual revenue of 73.66B KRW with 4.25% growth. MEDIPOST had revenue of 17.91B in the quarter ending December 31, 2025, with 0.40% growth.
Revenue
73.66B
Revenue Growth
+4.25%
P/S Ratio
10.75
Revenue / Employee
228.75M
Employees
322
Market Cap
791.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 73.66B | 3.00B | 4.25% |
| Dec 31, 2024 | 70.66B | 2.01B | 2.93% |
| Dec 31, 2023 | 68.64B | 4.44B | 6.92% |
| Dec 31, 2022 | 64.20B | 9.34B | 17.03% |
| Dec 31, 2021 | 54.86B | 6.23B | 12.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Cross Holdings | 2.45T |
| Chabiotech | 1.27T |
| Medy-Tox | 247.29B |
| Onconic Therapeutics | 53.39B |
| Pharmicell | 23.94B |
| SillaJen | 9.23B |
| GI Innovation | 5.84B |
| Genomictree | 3.76B |